Nicholas Lydon

Insider Reports History

Entity
Individual
Location
Blueprint Medicines Corp., 215 First Street, Suite 340/350, Cambridge, MA
Signature
/s/ Melissa Masse
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nicholas Lydon:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Blueprint Medicines Corp Director Common Stock 58K $6.1M $105.13 Jun 12, 2024 Direct
Blueprint Medicines Corp Director Stock Option (Right to Buy) 4.57K Jun 12, 2024 Direct

Insider Reports Filed by Nicholas Lydon

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BPMC Blueprint Medicines Corp Jun 12, 2024 2 $0 4 Jun 14, 2024 Director
BPMC Blueprint Medicines Corp Jun 21, 2023 2 $0 4 Jun 23, 2023 Director
BPMC Blueprint Medicines Corp Jun 21, 2022 2 $0 4 Jun 30, 2022 Director
BPMC Blueprint Medicines Corp May 23, 2022 2 $213K 4 May 25, 2022 Director
BPMC Blueprint Medicines Corp Jun 2, 2021 2 $0 4 Jun 4, 2021 Director